泰加保險(06161.HK):獲悉主要股東出售公司約4.79%股份
泰加保險(06161.HK)公布,收到一名第三方買方通知,於去年10月18日完成了一項場外交易,以總代價 3萬元向張德熙全資擁有的公司主要股東「IAML」收購3,000萬股公司股份,佔公司於該據稱轉讓進行時的全部已發行股本約4.79%。
公司並未收到買方及/或IAML的任何要求,在公司的股東名冊上登記該據稱轉讓。
公司股份已自本星期三(5日)起停止在聯交所買賣,公司股份將繼續暫停買賣,直至刊發內幕消息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.